Systems and methods for processing sensor data and end of life detection are provided. In some embodiments, a method for determining the end of life of a continuous analyte sensor includes evaluating a plurality of risk factors using an end of life function to determine an end of life status of the sensor and providing an output related to the end of life status of the sensor. The plurality of risk factors may be selected from the list including the number of days the sensor has been in use, whether there has been a decrease in signal sensitivity, whether there is a predetermined noise pattern, whether there is a predetermined oxygen concentration pattern, and error between reference BG values and EGV sensor values.

A control device according to an embodiment of the present disclosure is a control device for a robot that operates in a facility used by a user, and includes a state acquisition unit that acquires a biological state of the user, and a control unit that limits an operation of the robot when the biological state of the user is a sleep onset state. Here, when the biological state of the user is the sleep onset state, the control unit stops the operation of the robot or limits the operation of the robot to a set maximum operation speed or less.

An implant system includes an electrode portion comprising plural electrodes to perform nerve stimulation and nerve sensing, an impedance controller configured to selectively connect the plural electrodes between a stimulator to perform nerve stimulation and a sensor to perform nerve sensing based on a control signal, and set an impedance of each of the plural electrodes, and a processor configured to control a contact impedance by the plural electrodes by generating the control signal to control at least one of plural switches connected respectively to the plural electrodes, or variable resistors connected respectively to the plural electrodes, based on at least one of a selectively set purpose of the plural electrodes or a position of an electrode to which nerve stimulation is to be provided.

A patient monitor configured to receive patient-information electrical signals from an invasive patient sensor and a minimally invasive patient sensor, the patient monitor including a base unit and a detachable user interface unit for displaying hemodynamic parameters determined by the base unit. The base unit and user interface unit can be docked together, tethered together through a cabled connection, or physically separated from one another using wireless communication to transmit and receive information. The base unit and the user interface unit may pair before the user interface unit displays data to link the base unit with the user interface unit. The patient monitor can be configured to switch between invasive and minimally invasive monitoring of hemodynamic parameters of a patient, using invasive measurements to calibrate minimally invasive measurements.

The present disclosure relates to a body attachment device for continuous glucose monitoring and, more particularly, to a body attachment device for continuous glucose monitoring characterized in that as a user command for applying operating power of the body attachment device is inputted by an optical method or a touch method, operation of the body attachment device can be controlled by easily initiating application of battery power not only before the body attachment device is attached to the body but also after the body attachment device has been attached to the body. In addition, as the operation of the body attachment device is controlled by light or touch, it is possible to prevent erroneous operation of the body attachment device that occurs when a user touches, by mistake, a physical operation button formed in the body attachment device while using the body attachment device. Furthermore, the operating power can be stably provided.

A surgical instrument includes a movable handle movable relative a housing to manipulate an end effector assembly, and a latch assembly. The latch assembly includes a latch arm including a latch post, and a latch track defining an entry path, a latching path, a saddle, an un-latching path, and a return path. The latch post moves through the entry path, the latching path, and into the saddle upon movement of the movable handle from an un-actuated position to an over-actuated position and back to an actuated position to lock the movable handle. The latch post moves from the saddle through the un-latching path and the return path upon movement of the movable handle from actuated position to the over-actuated position and back to the un-actuated position. The return path includes a ramped surface configured to inhibit reverse travel of the latch post into the return path.

Embodiments provide systems, methods and apparatus for diabetes management using location-based reminders. Embodiments include requesting a user select a diabetes management related task to be reminded to perform; requesting the user select a location at which the user is to be reminded to perform the selected diabetes management related task; monitoring the user's location; detecting the user has entered the selected location; triggering the reminder in response to detecting the user has entered the selected location; and presenting the reminder to the user. Numerous other aspects are provided like helping a user locate a blood glucose meter (BGM) by identifying a most recent data transfer from the BGM based on a stored date and time associated with the most recent data transfer from the BGM, and identifying patterns of diabetes management events corresponding to particular location types.

The present disclosure relates to a continuous blood glucose measurement device and an applicator, wherein the continuous blood glucose measurement device is produced in a state in which a body attachment unit has been assembled inside an applicator, so as to minimize a user's additional work of attaching the body attachment unit to the body, thereby enabling the body attachment unit to be attached to the body only by simply activating the applicator. Particularly, the present invention provides a continuous blood glucose measurement device and an applicator, wherein the continuous blood glucose measurement device: includes a wireless communication chip in a body attachment unit so as to enable communication with an external terminal, thereby enabling simple and convenient use thereof, without additional work for connecting a separate transmitter, and easier maintenance; and is activated by a user's operation after the body attachment unit is attached to the body, so as to enable the operation start time to be adjusted to an appropriate time according to user's needs, and to enable the operation to start in a stabilized state so that blood glucose can be measured more accurately.

A surgical instrument is disclosed. The surgical instrument includes a control unit and a staple cartridge including a transponder. The control unit is configured to transmit a first wireless signal to the transponder and to receive a second wireless signal from the transponder to determine one of a first electronic state and a second electronic state of the transponder based on the second wireless signal.

Various analyte sensor systems for controlling activation of analyte sensor electronics circuitry are provided. Related methods for controlling analyte sensor electronics circuitry are also provided. Various analyte sensor systems for monitoring an analyte in a host are also provided. Various circuits for controlling activation of an analyte sensor system are also provided. Analyte sensor systems utilizing a state machine having a plurality of states for collecting a plurality of digital counts and waking a controller responsive to a wake up signal are also provided. Related methods for such analyte sensor systems are also provided. Systems for controlling activation of analyte sensor electronics circuitry utilizing a magnetic sensor are further provided. One or more display device configured to display one or more analyte concentration values are also provided.